- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Wall Street JournalEN
S
SABS
SAB BIOTHERAPEUTICS INC
2.79
0.25+9.84%Closed16:00 07/16 EDT
OPEN/PREV CLOSE2.803/2.540
TODAY RANGE2.591-2.980
VOL35.62K
MARKET CAP25.92M
52 WEEK RANGE1.000-5.01
AVG VOL (3M)48.11K
% TURNOVER0.38%
TURNOVER--
P/E (TTM)-0.7549
% RANGE15.31%
EPS(TTM)-3.6960
P/E(FORWARD)-1.4456
P/B1.211
BVPS2.304
DIVIDEND--
P/S19.59
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP20.47M
SHARES OUTSTANDING9.29M
NEXT EARNINGS08/06-08/11
FREE FLOAT7.34M
LOT SIZE1
EX-DATE01/05/2024
News
Press Releases
Financial Reports
Profile
Benzinga·05/29 21:06
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga·05/21 21:06
12 Health Care Stocks Moving In Wednesday's After-Market Session
Dow Jones·05/15 15:41
SAB Biotherapeutics Is Maintained at Buy by Chardan Capital
Dow Jones·05/15 15:41
SAB Biotherapeutics Price Target Maintained With a $20.00/Share by Chardan Capital
Benzinga·05/15 15:31
Chardan Capital Maintains Buy on SAB Biotherapeutics, Maintains $20 Price Target
Dow Jones·05/14 17:06
SAB Biotherapeutics Price Target Announced at $10.00/Share by HC Wainwright & Co.
Dow Jones·05/14 17:06
SAB Biotherapeutics Coverage Assumed by HC Wainwright & Co. at Buy
TipRanks·05/14 10:22
SAB Biotherapeutics assumed with a Buy at H.C. Wainwright
Seeking Alpha·05/09 13:55
SAB Biotherapeutics reports Q1 results
Dow Jones·05/09 13:01
*SAB Biotherapeutics 1Q Research and Development Expenses $7.7M >SABS
TipRanks·04/08 03:52
SAB Biotherapeutics Reports 2024 Financial Results and Advances T1D Therapy
Same Industry
Name/Symbol
Change%
Price